Pratidin
2026 · Economics Optional Paper II · 10 marksMainsQuestion 5a

Answer the following questions in about 150 words each :
Analyze the impact of the TRIPS Agreement on the pricing and availability of generic drugs in the Indian pharmaceutical sector.

10 marks · answer in 150 words · directive: Analyze

Answer

The core of a good answer

TRIPS ended India's process-patent regime and so removed the legal basis for copying new patented medicines, which threatened prices and supply of new generics; India used the flexibilities TRIPS allows (Section 3(d) and compulsory licensing) to keep most medicines generic and cheap, so the effect has been felt mainly on new, patented drugs.

An outline written by upsc.help, not an official UPSC answer; every fact checked by a separate review. How we work

What the question asks

The question asks for an analysis of cause and effect: how the shift from the Patents Act, 1970 to a TRIPS-compliant regime changed the price and availability of generic drugs. A balanced answer shows both the pressure TRIPS created and the safeguards India built in, with named cases.

Answer outline

Introduction

The Patents Act, 1970 allowed only process patents for drugs, which let Indian firms reverse-engineer molecules and made India a large supplier of low-cost generics. TRIPS (1995) required product patents for pharmaceuticals, which India restored from 2005, when the transition period for developing countries ended.

Changes TRIPS forced

Effect on pricing and availability

Flexibilities India used

Concerns

Conclusion

TRIPS has raised the cost of new patented medicines, but India's use of its flexibilities has kept generic supply largely intact; the continuing task is to defend these flexibilities in trade talks.

Examples and data to cite

Facts

Facts to remember

Sources used for the explanation

Write a timed answer in the app